Cell proliferation and apoptosis in stage III inoperable non-small cell lung carcinoma treated by radiotherapy

H Langendijk*, E Thunnissen, JW Arends, J de Jong, G ten Velde, R Lamers, D Guinee, J Holden, M Wouters

*Bijbehorende auteur voor dit werk

OnderzoeksoutputAcademicpeer review

26 Citaten (Scopus)


Purpose: The purpose of this study was to assess the prognostic value of the expression of p53 and bcl-2, the apoptotic index and the expression of topoisomerase II alpha in patients with inoperable non-small cell lung cancer (NSCLC) treated with high dose radiotherapy.

Patients and methods: A number of 161 patients with inoperable NSCLC treated with high dose radiotherapy (60 Gy) were included. Immunohistochemical analysis was used to assess the expression of nuclear p53-protein, topoisomerase II alpha and cytoplasmatic expression of bcl-2, while spontaneous apoptosis was assessed using in situ labeling. The minimal follow up period was 2 years.

Results: Local control did not only depend on the presence of p53 expression, but also on the proportion of p53 positive cells. The most important prognostic factor was the apoptotic index. A high apoptotic index was associated with worse local control, more distant metastases and a significantly worse overall survival. No association was noted between the expression of bcl-2 and topoisomerase II alpha with any of the endpoints.

Conclusion: This study indicates that p53 expression and the apoptotic index are prognostic factors with regard to local control in patients with inoperable NSCLC treated with radiotherapy and by combining these 2 factors, a clinically relevant estimation of the local control probability can be made. The apoptotic index turned out to be the only factor significantly related to survival. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.

Originele taal-2English
Pagina's (van-tot)197-207
Aantal pagina's11
TijdschriftRadiotherapy and Oncology
Nummer van het tijdschrift2
StatusPublished - aug.-2000

Citeer dit